Mechanisms of hyperthermia
Malignant Hyperthermia - Rare - Increased peripheral muscle activity due to ryanodine receptor issues - genetic component - Only seen with anesthesia - halothane, succinylcholine - Fast onset from exposure, severe and short lived - hyperK, muscle rigidity, autonomic instability, - increased CO2 on capnography Neuroleptic Malignant Syndrome - Due to altered DA transmission - seen with typical antipysch meds, lithium, environmental (heat) - Subacute, severe, lasts day-weeks - Lead pipe rigidity, autonomic instability, AMS Parkinsons Disease - abrupt withdraw of DA agonist therapy can cause hyperpyrexia Cocaine/ Stimulants - Hypothalamic stimulation, vasoconstriction, increased muscle activity - Fast onset, short duration, severe hyperthermia Serotonin Syndrome - Increased central 5HT activity - More common in drug drug interactions - SSRI/SSRI or SSRI & other serotonin agonists - TCA, demerol, linezolid, MAOI, tramadol, dextromethrophan (MAOI activity) - Subacute, moderate severity - AMS, muscle rigidity (LE>>UE), hyperreflexia & rigidity, autonomic instability - NBOME - designer drugs - increased serotonin activity OTHERS: Anticholinergic - increased muscarnic blockade Salicylate toxicity - uncouples cellular respiration Baclofen withdraw Complications from hyperthermia - Resp, PE, rhabdo, hepatic failure, hyperK Treatments - DC offending agents or restart withdrawn med - Physical cooling - Sedation - benzos, non depolarizing blockade - Secondary Treatments > Cyproheptadine - serotonin antagonist (for 5HT syndrome) - PO only > Dantrolene - for malignant hyperthermia - first line agent > Limited evidence for NMS - dantrolene has been tried - don't use as monotherapy > Dopamine agonist - bromocriptine, amantadine - dont use as monotherapy (long time to start acting) > ECT - unknown mechanism 54000 or 800-222-1222 - poison control
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |
Archives
August 2018
Categories
All
|